ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
This Quarter Return
+7.45%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$5.16B
AUM Growth
+$5.16B
(+32%)
Cap. Flow
+$1.13B
Cap. Flow
% of AUM
21.93%
Top 10 Holdings %
Top 10 Hldgs %
42.34%
Holding
1,276
New
184
Increased
654
Reduced
275
Closed
104
Top Buys
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
$493M |
| 2 |
Vanguard Information Technology ETF
VGT
|
$327M |
| 3 |
Vanguard Energy ETF
VDE
|
$152M |
| 4 |
Vanguard Industrials ETF
VIS
|
$118M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
$110M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$342M |
| 2 |
Vanguard Communication Services ETF
VOX
|
$225M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$219M |
| 4 |
Vanguard Long-Term Bond ETF
BLV
|
$152M |
| 5 |
Vanguard Intermediate-Term Bond ETF
BIV
|
$104M |
Sector Composition
| 1 | Technology | 13.31% |
| 2 | Healthcare | 6.99% |
| 3 | Communication Services | 6.92% |
| 4 | Consumer Discretionary | 6.11% |
| 5 | Energy | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Guardant Health
GH
$8.27B
| $2.9M | 0.06% |
+29,017
| New | +$2.9M |
|
202
CareDx
CDNA
$728M
| $2.89M | 0.06% |
63,451
+18,662
| +42% | +$849K |
|
203
Moderna
MRNA
$9.39B
| $2.88M | 0.06% |
11,328
+936
| +9% | +$238K |
|
204
Regeneron Pharmaceuticals
REGN
$61.6B
| $2.87M | 0.06% |
4,545
-547
| -11% | -$345K |
|
|
GOOD
205
Gladstone Commercial Corp
GOOD
$622M
| $2.87M | 0.06% |
111,283
-2,387
| -2% | -$61.5K |
|
206
Medpace
MEDP
$13.4B
| $2.85M | 0.06% |
13,105
-1,612
| -11% | -$351K |
|
|
CLLS
207
Cellectis
CLLS
$265M
| $2.82M | 0.05% |
347,174
+111,591
| +47% | +$906K |
|
208
Align Technology
ALGN
$9.77B
| $2.81M | 0.05% |
4,276
-274
| -6% | -$180K |
|
209
Axogen
AXGN
$712M
| $2.8M | 0.05% |
299,238
+92,543
| +45% | +$867K |
|
210
Health Catalyst
HCAT
$230M
| $2.74M | 0.05% |
69,127
+7,089
| +11% | +$281K |
|
211
QuidelOrtho
QDEL
$1.9B
| $2.72M | 0.05% |
20,147
-4,911
| -20% | -$663K |
|
|
NTST
212
NETSTREIT Corp
NTST
$1.71B
| $2.71M | 0.05% |
118,320
-5,254
| -4% | -$120K |
|
213
Exact Sciences
EXAS
$9.26B
| $2.67M | 0.05% |
34,362
+3,772
| +12% | +$294K |
|
214
Mercado Libre
MELI
$120B
| $2.67M | 0.05% |
1,980
+1,038
| +110% | +$1.4M |
|
215
Vertex Pharmaceuticals
VRTX
$102B
| $2.66M | 0.05% |
12,110
-3,346
| -22% | -$735K |
|
216
Stryker
SYK
$149B
| $2.64M | 0.05% |
9,888
-390
| -4% | -$104K |
|
217
Bristol-Myers Squibb
BMY
$97.3B
| $2.64M | 0.05% |
42,261
-217,899
| -84% | -$13.6M |
|
218
NovoCure
NVCR
$1.34B
| $2.62M | 0.05% |
34,861
+20,985
| +151% | +$1.58M |
|
219
Revvity
RVTY
$9.77B
| $2.59M | 0.05% |
12,885
-2,664
| -17% | -$536K |
|
220
Bio-Rad Laboratories Class A
BIO
$7.82B
| $2.57M | 0.05% |
3,399
-482
| -12% | -$364K |
|
221
Agilent Technologies
A
$35.2B
| $2.56M | 0.05% |
16,059
-199
| -1% | -$31.8K |
|
222
Vanguard Real Estate ETF
VNQ
$34.1B
| $2.54M | 0.05% |
21,864
+6,551
| +43% | +$760K |
|
|
NSTG
223
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.46M | 0.05% |
58,209
+13,308
| +30% | +$562K |
|
224
Vanguard Materials ETF
VAW
$2.86B
| $2.37M | 0.05% |
+12,017
| New | +$2.37M |
|
225
Vanguard Utilities ETF
VPU
$7.23B
| $2.32M | 0.05% |
+14,840
| New | +$2.32M |
|